| References |
Guyatt, G.H., Eikelboom, J.W., Gould, M.K., Garcia, D.A., Crowther, M., Murad, M.H., Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (2012) Chest, 141 (2), pp. e185S-e194S; Lowe, G.D., Prediction of postoperative deep-vein thrombosis (1997) Thromb. Haemost., 78 (1), pp. 47-52; Cohen, A.T., Applying risk assessment models in orthopaedic surgery: Effective risk stratification (1990) Blood Coagul. Fibrinolysis, 10, pp. 63-70; Zaw, H.M., Osborne, I.C., Pettit, P.N., Cohen, A.T., Risk factors for venous thromboembolism in orthopedic surgery (2002) Isr. Med. Assoc. J., 4 (11), pp. 1040-1042; Nicolaides, A.N., Fareed, J., Kakkar, A.K., Breddin, H.K., Goldhaber, S.Z., Hull, R., Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence) (2006) Int. Angiol., 25 (2), pp. 101-161; Geerts, W.H., Bergqvist, D., Pineo, G.F., Heit, J.A., Samama, C.M., Lassen, M.R., Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) (2008) Chest, (6), pp. 381S-453S; Stangier, J., Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate (2008) Clin. Pharmacokinet., 47 (5), pp. 285-295; Hauel, N.H., Nar, H., Priepke, H., Ries, U., Stessen, J.M., Wienen, W., Structure-based design of novel potent nonpeptide thrombin inhibitors (2002) J. Med. Chem., 45 (9), pp. 1757-1766; Lassen, M.R., Recent developments in the use of oral anticoagulants (2009) Expert Opin. Pharmacother., 10 (11), pp. 1769-1781; Freyburger, G., Macouillard, G., Labrouche, S., Sztark, F., Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement (2011) Thromb. Res., 127 (5), pp. 457-465; Lindahl, T.L., Baghaei, F., Blixter, I.F., Gustafsson, K.M., Stigendal, L., Sten-Linder, M., Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays (2011) Thromb. Haemost., 105 (2), pp. 371-378; Favaloro, E.J., Lippi, G., The new oral anticoagulants and the future of haemostasis laboratory testing (2012) Biochem. Med. (Zagreb)., 22 (3), pp. 329-341; Dobrovol'skiy, A.B., Titaeva, E.V., Thrombin formation and function in haemostasis (2013) Aterotromboz, (1), pp. 66-72. , in Russian; Kuznik, B.I., (2010) Cellular and Molecular Mechanisms for Regulation of the Hemostatic System in Health and Disease [Kletochnye i Molekulyarnye Mekhanizmy Regulyatsii Sistemy Gemostaza v Norme i Patologii], , Chita: Express-izdatel'stvo;, in Russian; Amiral, J., Walenga, J.M., Fareed, J., Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A. Semin (1984) Thromb. Hemost., 10 (4), pp. 228-242; Bernakevich, A.I., Vasil'ev, S.A., Es'kin, N.A., Hemostatic system in patients undergoing total hip arthroplasty (2009) Vestnik Travmatologii i Ortopedii Imeni N. N. Priorova, (1), pp. 37-42. , in Russian; Antropova, I.P., Yushkov, B.G., Activities of clotting, fibrinolytic, and anticoagulant components of plasma hemostasis in patients with degenerative diseases of large joints (2012) Byulleten' Eksperimental'noy Biologii i Meditsiny, 153 (4), pp. 495-498. , in Russian; Baeshko, A.A., Kryuchok, A.G., Yushkevich, V.A., Korsak, S.I., Postoperative pulmonary embolism (2000) Khirurgiya, (2), pp. 45-49. , in Russian; Perka, C., Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: Safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants (2011) Thromb. J., 9, p. 17; Rosencher, N., Vassilieff, N., Guigonis, V., Toulon, P., Conseiller, C., Comparison of effects of Elohes and albumin on hemostasis in orthopedic surgery (1992) Ann. Fr. Anesth. Reanim., 11 (5), pp. 526-530; Samama, M.M., Guinet, C., Le Flem, L., Ninin, E., Debue, J.M., Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: An observational study (2013) J. Thromb. Thrombolysis, 35 (2), pp. 140-146; Brueckner, S., Reinke, U., Roth-Isigkeit, A., Eleftheriadis, S., Schmucker, P., Siemens, H.J., Comparison of general and spinal anesthesia and their influence on hemostatic markers in patients undergoing total hip arthroplasty (2003) J. Clin. Anesth., 15 (6), pp. 433-440; López, Y., Paloma, M.J., Rifón, J., Cuesta, B., Páramo, J.A., Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states (1999) Thromb. Res., 93 (2), pp. 71-78; Bunescu, A., Widman, J., Lenkei, R., Menyes, P., Levin, K., Egberg, N., Increases in circulating levels of monocyte-platelet and neutrophilplatelet complexes following hip arthroplasty (2002) Clin. Sci. (Lond)., 102 (3), pp. 279-286; Misaki, T., Kitajima, I., Kabata, T., Tani, M., Kabata, C., Tsubokawa, T., Changes of the soluble fibrin monomer complex level during the perioperative period of hip replacement surgery (2008) J. Orthop. Sci., 13 (5), pp. 419-424; Heinrich, C., Kushner, I., Acute-phase proteins and other systemic responses to inflammation (1999) N. Engl. J. Med., 340 (6), pp. 448-454; Mann, K.G., Thrombin formation (2003) Chest, 124 (3), pp. 4S-10S |